Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1228

1.

Lack of evidence for human infection with Xenotropic murine leukemia virus-related virus in the Brazilian Amazon basin.

Gomes ST, Imbiriba L, Burbano RR, Silva AL, Feitosa RN, Cayres-Vallinoto IM, Ishak Mde O, Ishak R, Vallinoto AC.

Rev Soc Bras Med Trop. 2014 May-Jun;47(3):302-6.

PMID:
25075480
[PubMed - indexed for MEDLINE]
Free Article
2.

Induction of apoptosis in hormone-resistant human prostate cancer PC3 cells by inactivated Sendai virus.

Gao H, Gong XC, Chen ZD, Xu XS, Zhang Q, Xu XM.

Biomed Environ Sci. 2014 Jul;27(7):506-14. doi: 10.3967/bes2014.082.

PMID:
25073909
[PubMed - indexed for MEDLINE]
Free Article
3.

A novel approach for detecting viable and tissue-specific circulating tumor cells through an adenovirus-based reporter vector.

Wu P, Sokoll LJ, Kudrolli TA, Chowdhury WH, Ma R, Liu MM, Rodriguez R, Lupold SE.

Prostate. 2014 Sep;74(13):1286-96. doi: 10.1002/pros.22845. Epub 2014 Jul 25.

PMID:
25065656
[PubMed - indexed for MEDLINE]
4.

Bicalutamide-induced hepatotoxicity: A rare adverse effect.

Hussain S, Haidar A, Bloom RE, Zayouna N, Piper MH, Jafri SM.

Am J Case Rep. 2014 Jun 20;15:266-70. doi: 10.12659/AJCR.890679. eCollection 2014.

PMID:
24967002
[PubMed]
Free PMC Article
5.

Elevated HERV-K mRNA expression in PBMC is associated with a prostate cancer diagnosis particularly in older men and smokers.

Wallace TA, Downey RF, Seufert CJ, Schetter A, Dorsey TH, Johnson CA, Goldman R, Loffredo CA, Yan P, Sullivan FJ, Giles FJ, Wang-Johanning F, Ambs S, Glynn SA.

Carcinogenesis. 2014 Sep;35(9):2074-83. doi: 10.1093/carcin/bgu114. Epub 2014 May 23.

PMID:
24858205
[PubMed - indexed for MEDLINE]
6.

Prospective randomized phase 2 trial of intensity modulated radiation therapy with or without oncolytic adenovirus-mediated cytotoxic gene therapy in intermediate-risk prostate cancer.

Freytag SO, Stricker H, Lu M, Elshaikh M, Aref I, Pradhan D, Levin K, Kim JH, Peabody J, Siddiqui F, Barton K, Pegg J, Zhang Y, Cheng J, Oja-Tebbe N, Bourgeois R, Gupta N, Lane Z, Rodriguez R, DeWeese T, Movsas B.

Int J Radiat Oncol Biol Phys. 2014 Jun 1;89(2):268-76. doi: 10.1016/j.ijrobp.2014.02.034. Epub 2014 May 5.

PMID:
24837889
[PubMed - indexed for MEDLINE]
7.

Interleukin-6 induces neuroendocrine differentiation (NED) through suppression of RE-1 silencing transcription factor (REST).

Zhu Y, Liu C, Cui Y, Nadiminty N, Lou W, Gao AC.

Prostate. 2014 Aug;74(11):1086-94. doi: 10.1002/pros.22819. Epub 2014 May 12.

PMID:
24819501
[PubMed - indexed for MEDLINE]
8.

Schlafen 12 expression modulates prostate cancer cell differentiation.

Kovalenko PL, Basson MD.

J Surg Res. 2014 Jul;190(1):177-84. doi: 10.1016/j.jss.2014.03.069. Epub 2014 Mar 27.

PMID:
24768141
[PubMed - indexed for MEDLINE]
9.

Humoral response to a viral glycan correlates with survival on PROSTVAC-VF.

Campbell CT, Gulley JL, Oyelaran O, Hodge JW, Schlom J, Gildersleeve JC.

Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):E1749-58. doi: 10.1073/pnas.1314722111. Epub 2014 Apr 14.

PMID:
24733910
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Androgen-independent proliferation of LNCaP prostate cancer cells infected by xenotropic murine leukemia virus-related virus.

Kakoki K, Kamiyama H, Izumida M, Yashima Y, Hayashi H, Yamamoto N, Matsuyama T, Igawa T, Sakai H, Kubo Y.

Biochem Biophys Res Commun. 2014 Apr 25;447(1):216-22. doi: 10.1016/j.bbrc.2014.03.154. Epub 2014 Apr 8.

PMID:
24721431
[PubMed - indexed for MEDLINE]
11.

Preclinical safety assessment of Ad[I/PPT-E1A], a novel oncolytic adenovirus for prostate cancer.

Schenk E, Essand M, Kraaij R, Adamson R, Maitland NJ, Bangma CH.

Hum Gene Ther Clin Dev. 2014 Mar;25(1):7-15. doi: 10.1089/humc.2013.181.

PMID:
24649837
[PubMed - indexed for MEDLINE]
12.

Herpes simplex virus type 2 or human herpesvirus 8 infection and prostate cancer risk: A meta-analysis.

Ge X, Wang X, Shen P.

Biomed Rep. 2013 May;1(3):433-439. Epub 2013 Mar 19.

PMID:
24648964
[PubMed]
Free PMC Article
13.

Reduced 64Cu uptake and tumor growth inhibition by knockdown of human copper transporter 1 in xenograft mouse model of prostate cancer.

Cai H, Wu JS, Muzik O, Hsieh JT, Lee RJ, Peng F.

J Nucl Med. 2014 Apr;55(4):622-8. doi: 10.2967/jnumed.113.126979. Epub 2014 Mar 17.

PMID:
24639459
[PubMed - indexed for MEDLINE]
14.

Preclinical evaluation of imaging biomarkers for prostate cancer bone metastasis and response to cabozantinib.

Graham TJ, Box G, Tunariu N, Crespo M, Spinks TJ, Miranda S, Attard G, de Bono J, Eccles SA, Davies FE, Robinson SP.

J Natl Cancer Inst. 2014 Apr;106(4):dju033. doi: 10.1093/jnci/dju033. Epub 2014 Mar 14.

PMID:
24634505
[PubMed - indexed for MEDLINE]
15.

Making an avipoxvirus encoding a tumor-associated antigen and a costimulatory molecule.

Howley PM, Diener KR, Hayball JD.

Methods Mol Biol. 2014;1139:407-27. doi: 10.1007/978-1-4939-0345-0_32.

PMID:
24619696
[PubMed - indexed for MEDLINE]
16.

RapidCaP, a novel GEM model for metastatic prostate cancer analysis and therapy, reveals myc as a driver of Pten-mutant metastasis.

Cho H, Herzka T, Zheng W, Qi J, Wilkinson JE, Bradner JE, Robinson BD, Castillo-Martin M, Cordon-Cardo C, Trotman LC.

Cancer Discov. 2014 Mar;4(3):318-33. doi: 10.1158/2159-8290.CD-13-0346. Epub 2014 Jan 20.

PMID:
24444712
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Effects of TRPC6 on invasibility of low-differentiated prostate cancer cells.

Wang D, Li X, Liu J, Li J, Li LJ, Qiu MX.

Asian Pac J Trop Med. 2014 Jan;7(1):44-7. doi: 10.1016/S1995-7645(13)60190-X.

PMID:
24418082
[PubMed - indexed for MEDLINE]
18.

High RNA-binding motif protein 3 expression is an independent prognostic marker in operated prostate cancer and tightly linked to ERG activation and PTEN deletions.

Grupp K, Wilking J, Prien K, Hube-Magg C, Sirma H, Simon R, Steurer S, Budäus L, Haese A, Izbicki J, Sauter G, Minner S, Schlomm T, Tsourlakis MC.

Eur J Cancer. 2014 Mar;50(4):852-61. doi: 10.1016/j.ejca.2013.12.003. Epub 2013 Dec 28.

PMID:
24380696
[PubMed - indexed for MEDLINE]
19.

No detection of xenotropic murine leukemia virus-related viruses in prostate cancer in Sanandaj, west of Iran.

Khodabandehloo M, Hosseini W, Rahmani MR, Rezaee MA, Hakhamaneshi MS, Nikkhoo B, Jalili A.

Asian Pac J Cancer Prev. 2013;14(11):6929-33.

PMID:
24377628
[PubMed - indexed for MEDLINE]
Free Article
20.

Histone deacetylase inhibitors potentiate vesicular stomatitis virus oncolysis in prostate cancer cells by modulating NF-κB-dependent autophagy.

Shulak L, Beljanski V, Chiang C, Dutta SM, Van Grevenynghe J, Belgnaoui SM, Nguyên TL, Di Lenardo T, Semmes OJ, Lin R, Hiscott J.

J Virol. 2014 Mar;88(5):2927-40. doi: 10.1128/JVI.03406-13. Epub 2013 Dec 26.

PMID:
24371063
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk